Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa

Pathogens and Disease

Volumn 71, Issue 1, 2014, Pages 1-19

  Crabbé, Aurélie ^a   Ledesma, Maria A ^a   Nickerson, Cheryl A ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Cell differentiation; Cystic fibrosis; Epithelial injury; Host pathogen interactions; Microbiome; Three dimensional

Indexed keywords

HOST FACTOR; SCLEROPROTEIN; VIRULENCE FACTOR;

APICAL MEMBRANE; ARTICLE; BACTERIAL VIRULENCE; BASOLATERAL MEMBRANE; CELL CULTURE; CILIATED EPITHELIUM; ECOLOGICAL NICHE; EPITHELIUM; EXPERIMENTAL MODEL; HOST PATHOGEN INTERACTION; HUMAN; IN VITRO STUDY; INFECTION RISK; LUNG FIBROSIS; MICROENVIRONMENT; MICROFLORA; MUCOCILIARY CLEARANCE; MUCOSA; MUCOSAL IMMUNITY; MUCUS; NONHUMAN; ORGAN CULTURE; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONADACEAE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TISSUE CULTURE; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PATHOLOGY; THEORETICAL MODEL;

HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, THEORETICAL; MUCOUS MEMBRANE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84901980268     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12180     Document Type: Article

References (223)

1. Alarcon I, Kwan L, Yu C, Evans DJ & Fleiszig SM (2009) Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa. Infect Immun 77: 3264-3271.
2. Amitani R, Wilson R, Rutman A etal. (1991) Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol 4: 26-32.
3. Anderson GG, Kenney TF, Macleod DL, Henig NR & O'Toole GA (2013) Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination. Pathog Dis 67: 39-45.
4. Arita Y, Joseph A, Koo HC, Li Y, Palaia TA, Davis JM & Kazzaz JA (2004) Superoxide dismutase moderates basal and induced bacterial adherence and interleukin-8 expression in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 287: L1199-L1206.
5. Arora SK, Ritchings BW, Almira EC, Lory S & Ramphal R (1998) The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect Immun 66: 1000-1007.
6. Asgrimsson V, Gudjonsson T, Gudmundsson GH & Baldursson O (2006) Novel effects of azithromycin on tight junction proteins in human airway epithelia. Antimicrob Agents Chemother 50: 1805-1812.
7. Azghani AO, Gray LD & Johnson AR (1993) A bacterial protease perturbs the paracellular barrier function of transporting epithelial monolayers in culture. Infect Immun 61: 2681-2686.
8. Babrowski T, Romanowski K, Fink D, Kim M, Gopalakrishnan V, Zaborina O & Alverdy JC (2013) The intestinal environment of surgical injury transforms Pseudomonas aeruginosa into a discrete hypervirulent morphotype capable of causing lethal peritonitis. Surgery 153: 36-43.
9. Bajolet-Laudinat O, Girod-de Bentzmann S, Tournier JM, Madoulet C, Plotkowski MC, Chippaux C & Puchelle E (1994) Cytotoxicity of Pseudomonas aeruginosa internal lectin PA-I to respiratory epithelial cells in primary culture. Infect Immun 62: 4481-4487.
10. Banin E, Vasil ML & Greenberg EP (2005) Iron and Pseudomonas aeruginosa biofilm formation. P Natl Acad Sci USA 102: 11076-11081.
11. Barasch J & Al-Awqati Q (1993) Defective acidification of the biosynthetic pathway in cystic fibrosis. J Cell Sci Suppl 17: 229-233.
12. Barrila J, Radtke AL, Crabbé A, Sarker SF, Herbst-Kralovetz MM, Ott CM & Nickerson CA (2010) Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat Rev Microbiol 8: 791-801.
13. Bebok Z, Tousson A, Schwiebert LM & Venglarik CJ (2001) Improved oxygenation promotes CFTR maturation and trafficking in MDCK monolayers. Am J Physiol Cell Physiol 280: C135-C145.
14. Bebok Z, Collawn JF, Wakefield J etal. (2005) Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers. J Physiol 569: 601-615.
15. Bitterle E, Karg E, Schroeppel A etal. (2006) Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles. Chemosphere 65: 1784-1790.
16. Blake J (1973) A note on mucus shear rates. Respir Physiol 17: 394-399.
17. Boat TF, Cheng P & Wood RE (1997) Tracheobronchial mucus secretion in vivo and in vitro by epithelial tissues from cystic fibrosis and control subjects. Mod Probl Paediatr 19: 141-152.
18. Boudreau N & Bissell MJ (1998) Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10: 640-646.
19. Breidenstein EB, de la Fuente-Nunez C & Hancock RE (2011) Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 19: 419-426.
20. Bucior I, Mostov K & Engel JN (2010) Pseudomonas aeruginosa-mediated damage requires distinct receptors at the apical and basolateral surfaces of the polarized epithelium. Infect Immun 78: 939-953.
21. Bucior I, Pielage JF & Engel JN (2012) Pseudomonas aeruginosa pili and flagella mediate distinct binding and signaling events at the apical and basolateral surface of airway epithelium. PLoS Pathog 8: e1002616.
22. Bucior I, Abbott J, Song Y, Matthay MA & Engel JN (2013) Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol 305: L352-L363.
23. Buisine MP, Devisme L, Copin MC, Durand-Reville M, Gosselin B, Aubert JP & Porchet N (1999) Developmental mucin gene expression in the human respiratory tract. Am J Respir Cell Mol Biol 20: 209-218.
24. Carnoy C, Scharfman A, Van Brussel E, Lamblin G, Ramphal R & Roussel P (1994) Pseudomonas aeruginosa outer membrane adhesins for human respiratory mucus glycoproteins. Infect Immun 62: 1896-1900.
25. Carterson AJ, Honer Zu Bentrup K, Ott CM etal. (2005) A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect Immun 73: 1129-1140.
26. Chu H & Mazmanian SK (2013) Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol 14: 668-675.
27. Chun CK, Ozer EA, Welsh MJ, Zabner J & Greenberg EP (2004) Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. P Natl Acad Sci USA 101: 3587-3590.
28. Coakley RD, Grubb BR, Paradiso AM etal. (2003) Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. P Natl Acad Sci USA 100: 16083-16088.
29. Cornelis P & Dingemans J (2013) Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front Cell Infect Microbiol 3: 75.
30. Cortiella J, Niles J, Cantu A etal. (2010) Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A 16: 2565-2580.
31. Cory TJ, Birket SE, Murphy BS, Mattingly C, Breslow-Deckman JM & Feola DJ (2013) Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa. J Antimicrob Chemother 68: 840-851.
32. Cox MJ, Allgaier M, Taylor B etal. (2010) Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 5: e11044.
33. Cozens AL, Yezzi MJ, Kunzelmann K etal. (1994) CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10: 38-47.
34. Crabbé A, De Boever P, Van Houdt R, Moors H, Mergeay M & Cornelis P (2008) Use of the rotating wall vessel technology to study the effect of shear stress on growth behaviour of Pseudomonas aeruginosa PA01. Environ Microbiol 10: 2098-2110.
35. Crabbé A, Pycke B, Van Houdt R, Monsieurs P, Nickerson C, Leys N & Cornelis P (2010) Response of Pseudomonas aeruginosa PAO1 to low shear modelled microgravity involves AlgU regulation. Environ Microbiol 12: 1545-1564.
36. Crabbé A, Sarker SF, Van Houdt R, Ott CM, Leys N, Cornelis P & Nickerson CA (2011) Alveolar epithelium protects macrophages from quorum sensing-induced cytotoxicity in a three-dimensional co-culture model. Cell Microbiol 13: 469-481.
37. Daly AB, Wallis JM, Borg ZD etal. (2012) Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng Part A 18: 1-16.
38. de Bentzmann S, Roger P & Puchelle E (1996a) Pseudomonas aeruginosa adherence to remodelling respiratory epithelium. Eur Respir J 9: 2145-2150.
39. de Bentzmann S, Plotkowski C & Puchelle E (1996b) Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium. Am J Respir Crit Care Med 154: S155-S162.
40. de Bentzmann S, Roger P, Dupuit F, Bajolet-Laudinat O, Fuchey C, Plotkowski MC & Puchelle E (1996c) Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect Immun 64: 1582-1588.
41. de Courcey F, Zholos AV, Atherton-Watson H etal. (2012) Development of primary human nasal epithelial cell cultures for the study of cystic fibrosis pathophysiology. Am J Physiol Cell Physiol 303: C1173-C1179.
42. Doring G, Flume P, Heijerman H & Elborn JS (2012) Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros 11: 461-479.
43. Dosanjh A, Lencer W, Brown D, Ausiello DA & Stow JL (1994) Heterologous expression of delta F508 CFTR results in decreased sialylation of membrane glycoconjugates. Am J Physiol 266: C360-C366.
44. Dowling RB, Johnson M, Cole PJ & Wilson R (1997a) The effect of rolipram, a type IV phosphodiesterase inhibitor, on Pseudomonas aeruginosa infection of respiratory mucosa. J Pharmacol Exp Ther 282: 1565-1571.
45. Dowling RB, Rayner CF, Rutman A etal. (1997b) Effect of salmeterol on Pseudomonas aeruginosa infection of respiratory mucosa. Am J Respir Crit Care Med 155: 327-336.
46. Dowling RB, Johnson M, Cole PJ & Wilson R (1999) Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro. Eur Respir J 14: 363-369.
47. Duan K, Dammel C, Stein J, Rabin H & Surette MG (2003) Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50: 1477-1491.
48. Duell BL, Cripps AW, Schembri MA & Ulett GC (2011) Epithelial cell coculture models for studying infectious diseases: benefits and limitations. J Biomed Biotechnol 2011: 852419.
49. Dupuit F, Kalin N, Brezillon S, Hinnrasky J, Tummler B & Puchelle E (1995) CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium. J Clin Invest 96: 1601-1611.
50. Dvorak A, Tilley AE, Shaykhiev R, Wang R & Crystal RG (2011) Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am J Respir Cell Mol Biol 44: 465-473.
51. Eloe-Fadrosh EA & Rasko DA (2013) The human microbiome: from symbiosis to pathogenesis. Annu Rev Med 64: 145-163.
52. Engel J & Eran Y (2011) Subversion of mucosal barrier polarity by Pseudomonas aeruginosa. Front Microbiol 2: 114.
53. Evans CM & Koo JS (2009) Airway mucus: the good, the bad, the sticky. Pharmacol Ther 121: 332-348.
54. Farberman MM, Ibricevic A, Joseph TD etal. (2011) Effect of polarized release of CXC-chemokines from wild-type and cystic fibrosis murine airway epithelial cells. Am J Respir Cell Mol Biol 45: 221-228.
55. Farley MM, Stephens DS, Mulks MH, Cooper MD, Bricker JV, Mirra SS & Wright A (1986) Pathogenesis of IgA1 protease-producing and -nonproducing Haemophilus influenzae in human nasopharyngeal organ cultures. J Infect Dis 154: 752-759.
56. Fleiszig SM, Evans DJ, Do N, Vallas V, Shin S & Mostov KE (1997) Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect Immun 65: 2861-2867.
57. Fleiszig SM, Vallas V, Jun CH, Mok L, Balkovetz DF, Roth MG & Mostov KE (1998) Susceptibility of epithelial cells to Pseudomonas aeruginosa invasion and cytotoxicity is upregulated by hepatocyte growth factor. Infect Immun 66: 3443-3446.
58. Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Hoiby N & Molin S (2012) Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol 10: 841-851.
59. Forde E, Humphreys H, Greene CM, Fitzgerald-Hughes D & Devocelle M (2014) Potential of host defense Peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis. Antimicrob Agents Chemother 58: 978-985.
60. Forman HJ & Torres M (2002) Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166: S4-S8.
61. Forsgren J, Samuelson A, Ahlin A, Jonasson J, Rynnel-Dagoo B & Lindberg A (1994) Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect Immun 62: 673-679.
62. Fung C, Naughton S, Turnbull L etal. (2010) Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J Med Microbiol 59: 1089-1100.
63. Garnett JP, Gray MA, Tarran R, Brodlie M, Ward C, Baker EH & Baines DL (2013) Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth. PLoS One 8: e76283.
64. Gassama-Diagne A, Yu W, Ter Beest M, Martin-Belmonte F, Kierbel A, Engel J & Mostov K (2006) Phosphatidylinositol-3, 4, 5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat Cell Biol 8: 963-970.
65. Gellatly SL & Hancock RE (2013) Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis 67: 159-173.
66. Grandel U, Heygster D, Sibelius U etal. (2009) Amplification of lipopolysaccharide-induced cytokine synthesis in non-small cell lung cancer/neutrophil cocultures. Mol Cancer Res 7: 1729-1735.
67. Grasemann H, Kurtz F & Ratjen F (2006) Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. Am J Respir Crit Care Med 174: 208-212.
68. Gray T, Coakley R, Hirsh A etal. (2004) Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1beta in human bronchial epithelia. Am J Physiol Lung Cell Mol Physiol 286: L320-L330.
69. Griffith LG & Swartz MA (2006) Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7: 211-224.
70. Groneberg DA, Peiser C, Dinh QT etal. (2003) Distribution of respiratory mucin proteins in human nasal mucosa. Laryngoscope 113: 520-524.
71. Grumbach Y, Quynh NV, Chiron R & Urbach V (2009) LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells. Am J Physiol Lung Cell Mol Physiol 296: L101-L108.
72. Guzman JR, Conlin VS & Jobin C (2013) Diet, microbiome, and the intestinal epithelium: an essential triumvirate? Biomed Res Int 2013: 425146.
73. Halldorsson S, Gudjonsson T, Gottfredsson M, Singh PK, Gudmundsson GH & Baldursson O (2010) Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 42: 62-68.
74. Han MK, Huang YJ, Lipuma JJ etal. (2012) Significance of the microbiome in obstructive lung disease. Thorax 67: 456-463.
75. Hassett DJ, Cuppoletti J, Trapnell B etal. (2002) Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev 54: 1425-1443.
76. Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC & Matu JO (2009) Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol 17: 130-138.
77. Hattrup CL & Gendler SJ (2008) Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 70: 431-457.
78. Heiniger RW, Winther-Larsen HC, Pickles RJ, Koomey M & Wolfgang MC (2010) Infection of human mucosal tissue by Pseudomonas aeruginosa requires sequential and mutually dependent virulence factors and a novel pilus-associated adhesin. Cell Microbiol 12: 1158-1173.
79. Henke MO, Renner A, Huber RM, Seeds MC & Rubin BK (2004) MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 31: 86-91.
80. Henke MO, John G, Germann M, Lindemann H & Rubin BK (2007) MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Am J Respir Crit Care Med 175: 816-821.
81. Higbee RG, Byers AM, Dhir V etal. (2009) An immunologic model for rapid vaccine assessment - a clinical trial in a test tube. Altern Lab Anim 37(suppl 1): 19-27.
82. Hingley ST, Hastie AT, Kueppers F & Higgins ML (1986a) Disruption of respiratory cilia by proteases including those of Pseudomonas aeruginosa. Infect Immun 54: 379-385.
83. Hingley ST, Hastie AT, Kueppers F, Higgins ML, Weinbaum G & Shryock T (1986b) Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia. Infect Immun 51: 254-262.
84. Hirota SA, Fines K & Ng J etal. (2010) Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology 139: 259-269.
85. Hoentsch M, von Woedtke T, Weltmann KD & Nebe JB (2012) Time-dependent effects of low-temperature atmospheric-pressure argon plasma on epithelial cell attachment, viability and tight junction formation in vitro. J Phys D: Appl Phys 45: 1-9.
86. Hoffman LR, Richardson AR, Houston LS etal. (2010) Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 6: e1000712.
87. Hoiby N (2011) Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med 9: 32.
88. Hoiby N, Ciofu O & Bjarnsholt T (2010) Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5: 1663-1674.
89. Holmes E, Li JV, Marchesi JR & Nicholson JK (2012) Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab 16: 559-564.
90. Honer Zu Bentrup K, Ramamurthy R, Ott CM etal. (2006) Three-dimensional organotypic models of human colonic epithelium to study the early stages of enteric salmonellosis. Microbes Infect 8: 1813-1825.
91. Hovenberg HW, Davies JR & Carlstedt I (1996) Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem J 318(Pt 1): 319-324.
92. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY & Ingber DE (2010) Reconstituting organ-level lung functions on a chip. Science 328: 1662-1668.
93. Huh D, Hamilton GA & Ingber DE (2011) From 3D cell culture to organs-on-chips. Trends Cell Biol 21: 745-754.
94. Hunter RC, Asfour F, Dingemans J etal. (2013) Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. MBio 4: e00557-e00613.
95. Inman JL & Bissell MJ (2010) Apical polarity in three-dimensional culture systems: where to now? J Biol 9: 2.
96. Jackson AD, Rayner CF, Dewar A, Cole PJ & Wilson R (1996) A human respiratory-tissue organ culture incorporating an air interface. Am J Respir Crit Care Med 153: 1130-1135.
97. Jain S, Suzuki T, Seth A, Samak G & Rao R (2011) Protein kinase Czeta phosphorylates occludin and promotes assembly of epithelial tight junctions. Biochem J 437: 289-299.
98. Kanthakumar K, Cundell DR, Johnson M, Wills PJ, Taylor GW, Cole PJ & Wilson R (1994) Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin. Br J Pharmacol 112: 493-498.
99. Kau AL, Ahern PP, Griffin NW, Goodman AL & Gordon JI (2011) Human nutrition, the gut microbiome and the immune system. Nature 474: 327-336.
100. Kazmierczak BI, Mostov K & Engel JN (2004) Epithelial cell polarity alters Rho-GTPase responses to Pseudomonas aeruginosa. Mol Biol Cell 15: 411-419.
101. Kierbel A, Gassama-Diagne A, Mostov K & Engel JN (2005) The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell 16: 2577-2585.
102. Kierbel A, Gassama-Diagne A, Rocha C, Radoshevich L, Olson J, Mostov K & Engel J (2007) Pseudomonas aeruginosa exploits a PIP3-dependent pathway to transform apical into basolateral membrane. J Cell Biol 177: 21-27.
103. Kim KJ, Borok Z & Crandall ED (2001) A useful in vitro model for transport studies of alveolar epithelial barrier. Pharm Res 18: 253-255.
104. Kleinman HK & Martin GR (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15: 378-386.
105. Kluge S, Hoffmann M, Benndorf D, Rapp E & Reichl U (2012) Proteomic tracking and analysis of a bacterial mixed culture. Proteomics 12: 1893-1901.
106. Kohler JE, Zaborina O, Wu L etal. (2005) Components of intestinal epithelial hypoxia activate the virulence circuitry of Pseudomonas. Am J Physiol Gastrointest Liver Physiol 288: G1048-G1054.
107. Kohler T, Perron GG, Buckling A & van Delden C (2010) Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog 6: e1000883.
108. Kube D, Adams L, Perez A & Davis PB (2001) Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport. Am J Physiol Lung Cell Mol Physiol 280: L482-L492.
109. Kube DM, Fletcher D & Davis PB (2005) Relation of exaggerated cytokine responses of CF airway epithelial cells to PAO1 adherence. Respir Res 6: 69.
110. Law RJ, Gur-Arie L, Rosenshine I & Finlay BB (2013) In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med 3: a009977.
111. Lee VT, Smith RS, Tummler B & Lory S (2005) Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect Immun 73: 1695-1705.
112. Lehmann AD, Daum N, Bur M, Lehr CM, Gehr P & Rothen-Rutishauser BM (2011) An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur J Pharm Biopharm 77: 398-406.
113. Leonard F, Collnot EM & Lehr CM (2010) A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. Mol Pharm 7: 2103-2119.
114. Lepanto P, Bryant DM, Rossello J, Datta A, Mostov KE & Kierbel A (2011) Pseudomonas aeruginosa interacts with epithelial cells rapidly forming aggregates that are internalized by a Lyn-dependent mechanism. Cell Microbiol 13: 1212-1222.
115. LeSimple P, Liao J, Robert R, Gruenert DC & Hanrahan JW (2010) Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers. J Physiol 588: 1195-1209.
116. Li JD, Dohrman AF, Gallup M etal. (1997) Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. P Natl Acad Sci USA 94: 967-972.
117. Lieberman D (2003) Pseudomonal infections in patients with COPD: epidemiology and management. Am J Respir Med 2: 459-468.
118. Lillehoj EP, Hyun SW, Kim BT, Zhang XG, Lee DI, Rowland S & Kim KC (2001) Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 280: L181-L187.
119. Lillehoj EP, Kim BT & Kim KC (2002) Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin. Am J Physiol Lung Cell Mol Physiol 282: L751-L756.
120. Loffing-Cueni D, Loffing J, Shaw C, Taplin AM, Govindan M, Stanton CR & Stanton BA (2001) Trafficking of GFP-tagged DeltaF508-CFTR to the plasma membrane in a polarized epithelial cell line. Am J Physiol Cell Physiol 281: C1889-C1897.
121. Long J, Zaborina O, Holbrook C, Zaborin A & Alverdy J (2008) Depletion of intestinal phosphate after operative injury activates the virulence of P. aeruginosa causing lethal gut-derived sepsis. Surgery 144: 189-197.
122. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK & Knight R (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489: 220-230.
123. Lu W, Hisatsune A, Koga T etal. (2006) Cutting edge: enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice. J Immunol 176: 3890-3894.
124. Mallants R, Jorissen M & Augustijns P (2008) Beneficial effect of antibiotics on ciliary beat frequency of human nasal epithelial cells exposed to bacterial toxins. J Pharm Pharmacol 60: 437-443.
125. Marchiando AM, Graham WV & Turner JR (2010) Epithelial barriers in homeostasis and disease. Annu Rev Pathol 5: 119-144.
126. Martin C, Thevenot G, Danel S etal. (2011) Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo. Eur Respir J 38: 939-946.
127. Martino AT, Mueller C, Braag S, Cruz PE, Campbell-Thompson M, Jin S & Flotte TR (2011) N-glycosylation augmentation of the cystic fibrosis epithelium improves Pseudomonas aeruginosa clearance. Am J Respir Cell Mol Biol 44: 824-830.
128. Marx U, Walles H, Hoffmann S etal. (2012) 'Human-on-a-chip' developments: a translational cutting-edge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man? Altern Lab Anim 40: 235-257.
129. Mathee K, Ciofu O, Sternberg C etal. (1999) Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145(Pt 6): 1349-1357.
130. Matsui H, Wagner VE, Hill DB etal. (2006) A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. P Natl Acad Sci USA 103: 18131-18136.
131. McNamara N, Khong A, McKemy D, Caterina M, Boyer J, Julius D & Basbaum C (2001) ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor. P Natl Acad Sci USA 98: 9086-9091.
132. Melby EL, Jacobsen J, Olsnes S & Sandvig K (1993) Entry of protein toxins in polarized epithelial cells. Cancer Res 53: 1755-1760.
133. Mendez JJ, Ghaedi M, Steinbacher D & Niklason L (2014) Epithelial cell differentiation of human mesenchymal stromal cells in decellularized lung scaffolds. Tissue Eng Part A [Epub ahead of print].
134. Middleton AM, Keig P & Wilson R (2003) In vitro models of infection I-human respiratory tissue organ culture. Methods Mol Med 71: 277-295.
135. Mitchell E, Houles C, Sudakevitz D etal. (2002) Structural basis for oligosaccharide-mediated adhesion of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. Nat Struct Biol 9: 918-921.
136. Moreau-Marquis S, Stanton BA & O'Toole GA (2008a) Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm Pharmacol Ther 21: 595-599.
137. Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O'Toole GA & Stanton BA (2008b) The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Lung Cell Mol Physiol 295: L25-L37.
138. Moreau-Marquis S, O'Toole GA & Stanton BA (2009) Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol 41: 305-313.
139. Morris AP, Cunningham SA, Tousson A, Benos DJ & Frizzell RA (1994) Polarization-dependent apical membrane CFTR targeting underlies cAMP-stimulated Cl- secretion in epithelial cells. Am J Physiol 266: C254-C268.
140. Munro NC, Barker A, Rutman A etal. (1989) Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity. J Appl Physiol (1985) 67: 316-323.
141. Nelson RK, Poroyko V, Morowitz MJ, Liu D & Alverdy JC (2013) Effect of dietary monosaccharides on Pseudomonas aeruginosa virulence. Surg Infect (Larchmt) 14: 35-42.
142. Nickerson CA, Goodwin TJ, Terlonge J etal. (2001) Three-dimensional tissue assemblies: novel models for the study of Salmonella enterica serovar Typhimurium pathogenesis. Infect Immun 69: 7106-7120.
143. Olson N, Hristova M, Heintz NH, Lounsbury KM & van der Vliet A (2011) Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 301: L993-L1002.
144. Ott HC, Clippinger B, Conrad C etal. (2010) Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 16: 927-933.
145. Ozer EA, Pezzulo A, Shih DM etal. (2005) Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing. FEMS Microbiol Lett 253: 29-37.
146. Palmer KL, Aye LM & Whiteley M (2007) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189: 8079-8087.
147. Paradiso AM, Coakley RD & Boucher RC (2003) Polarized distribution of HCO3- transport in human normal and cystic fibrosis nasal epithelia. J Physiol 548: 203-218.
148. Patriquin GM, Banin E, Gilmour C, Tuchman R, Greenberg EP & Poole K (2008) Influence of quorum sensing and iron on twitching motility and biofilm formation in Pseudomonas aeruginosa. J Bacteriol 190: 662-671.
149. Petersen TH, Calle EA, Colehour MB & Niklason LE (2012) Matrix composition and mechanics of decellularized lung scaffolds. Cells Tissues Organs 195: 222-231.
150. Pezzulo AA, Tang XX, Hoegger MJ etal. (2012) Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487: 109-113.
151. Pier GB (2012) The challenges and promises of new therapies for cystic fibrosis. J Exp Med 209: 1235-1239.
152. Pier GB, Grout M, Zaidi TS & Goldberg JB (1996a) How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Crit Care Med 154: S175-S182.
153. Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR & Goldberg JB (1996b) Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271: 64-67.
154. Pier GB, Grout M & Zaidi TS (1997) Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. P Natl Acad Sci USA 94: 12088-12093.
155. Plotkowski MC, Beck G, Tournier JM, Bernardo-Filho M, Marques EA & Puchelle E (1989) Adherence of Pseudomonas aeruginosa to respiratory epithelium and the effect of leucocyte elastase. J Med Microbiol 30: 285-293.
156. Plotkowski MC, Chevillard M, Pierrot D, Altemayer D, Zahm JM, Colliot G & Puchelle E (1991) Differential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture. J Clin Invest 87: 2018-2028.
157. Plotkowski MC, Chevillard M, Pierrot D, Altemayer D & Puchelle E (1992) Epithelial respiratory cells from cystic fibrosis patients do not possess specific Pseudomonas aeruginosa-adhesive properties. J Med Microbiol 36: 104-111.
158. Plotkowski MC, Tournier JM & Puchelle E (1996) Pseudomonas aeruginosa strains possess specific adhesins for laminin. Infect Immun 64: 600-605.
159. Plotkowski MC, de Bentzmann S, Pereira SH, Zahm JM, Bajolet-Laudinat O, Roger P & Puchelle E (1999) Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity. Am J Respir Cell Mol Biol 20: 880-890.
160. Puchelle E, Zahm JM, Tournier JM & Coraux C (2006) Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 3: 726-733.
161. Quinton PM (2008) Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 372: 415-417.
162. Quinton PM (2010) Role of epithelial HCO3(-) transport in mucin secretion: lessons from cystic fibrosis. Am J Physiol Cell Physiol 299: C1222-C1233.
163. Radtke AL, Wilson JW, Sarker S & Nickerson CA (2011) Analysis of interactions of Salmonella type three secretion mutants with 3-D intestinal epithelial cells. PLoS One 5: e15750.
164. Ramphal R & Pyle M (1983) Adherence of mucoid and nonmucoid Pseudomonas aeruginosa to acid-injured tracheal epithelium. Infect Immun 41: 345-351.
165. Read RC, Roberts P, Munro N etal. (1992) Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol (1985) 72: 2271-2277.
166. Reid DW, Carroll V, O'May C, Champion A & Kirov SM (2007) Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Eur Respir J 30: 286-292.
167. Rejman J, Di Gioia S, Bragonzi A & Conese M (2007) Pseudomonas aeruginosa infection destroys the barrier function of lung epithelium and enhances polyplex-mediated transfection. Hum Gene Ther 18: 642-652.
168. Rock JR & Hogan BL (2011) Epithelial progenitor cells in lung development, maintenance, repair, and disease. Annu Rev Cell Dev Biol 27: 493-512.
169. Roger P, Puchelle E, Bajolet-Laudinat O etal. (1999) Fibronectin and alpha5beta1 integrin mediate binding of Pseudomonas aeruginosa to repairing airway epithelium. Eur Respir J 13: 1301-1309.
170. Romanowski K, Zaborin A, Fernandez H etal. (2011) Prevention of siderophore-mediated gut-derived sepsis due to P. aeruginosa can be achieved without iron provision by maintaining local phosphate abundance: role of pH. BMC Microbiol 11: 212.
171. Rubin BK (2007) Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev 8: 4-7.
172. Sadikot RT, Blackwell TS, Christman JW & Prince AS (2005) Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171: 1209-1223.
173. Sagel SD, Davis SD, Campisi P & Dell SD (2011) Update of respiratory tract disease in children with primary ciliary dyskinesia. Proc Am Thorac Soc 8: 438-443.
174. Saiman L, Ishimoto K, Lory S & Prince A (1990) The effect of piliation and exoproduct expression on the adherence of Pseudomonas aeruginosa to respiratory epithelial monolayers. J Infect Dis 161: 541-548.
175. Sajjan U, Moreira J, Liu M, Humar A, Chaparro C, Forstner J & Keshavjee S (2004) A novel model to study bacterial adherence to the transplanted airway: inhibition of Burkholderia cepacia adherence to human airway by dextran and xylitol. J Heart Lung Transplant 23: 1382-1391.
176. Schaible B, McClean S, Selfridge A, Broquet A, Asehnoune K, Taylor CT & Schaffer K (2013) Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa. PLoS One 8: e56491.
177. Schmeichel KL & Bissell MJ (2003) Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci 116: 2377-2388.
178. Schobert M & Jahn D (2010) Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int J Med Microbiol 300: 549-556.
179. Schobert M & Tielen P (2010) Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa. Future Microbiol 5: 603-621.
180. Schroeder TH, Zaidi T & Pier GB (2001) Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells. Infect Immun 69: 719-729.
181. Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerceker AA, Golan DE & Pier GB (2002) CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. P Natl Acad Sci USA 99: 6907-6912.
182. Schulz BL, Sloane AJ, Robinson LJ etal. (2005) Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions. Biochem J 387: 911-919.
183. Sharma P, Dudus L, Nielsen PA, Clausen H, Yankaskas JR, Hollingsworth MA & Engelhardt JF (1998) MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol 19: 30-37.
184. Simon-Assmann P, Lefebvre O, Bellissent-Waydelich A, Olsen J, Orian-Rousseau V & De Arcangelis A (1998) The laminins: role in intestinal morphogenesis and differentiation. Ann NY Acad Sci 859: 46-64.
185. Song Y, Salinas D, Nielson DW & Verkman AS (2006) Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis. Am J Physiol Cell Physiol 290: C741-C749.
186. Soong G, Parker D, Magargee M & Prince AS (2008) The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function. J Bacteriol 190: 2814-2821.
187. Srikanth CV, Mercado-Lubo R, Hallstrom K & McCormick BA (2011) Salmonella effector proteins and host-cell responses. Cell Mol Life Sci 68: 3687-3697.
188. Sriramulu DD, Lunsdorf H, Lam JS & Romling U (2005) Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 54: 667-676.
189. Swartz MA, Tschumperlin DJ, Kamm RD & Drazen JM (2001) Mechanical stress is communicated between different cell types to elicit matrix remodeling. P Natl Acad Sci USA 98: 6180-6185.
190. Swiatecka-Urban A, Moreau-Marquis S, Maceachran DP etal. (2006) Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells. Am J Physiol Cell Physiol 290: C862-C872.
191. Tang XX, Fok KL, Chen H etal. (2012) Lymphocyte CFTR promotes epithelial bicarbonate secretion for bacterial killing. J Cell Physiol 227: 3887-3894.
192. Tarran R, Button B, Picher M etal. (2005) Normal and cystic fibrosis airway surface liquid homeostasis. The effects of phasic shear stress and viral infections. J Biol Chem 280: 35751-35759.
193. Teiber JF, Horke S, Haines DC etal. (2008) Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone. Infect Immun 76: 2512-2519.
194. Trafny EA, Stepinska M, Antos M & Grzybowski J (1995) Effects of free and liposome-encapsulated antibiotics on adherence of Pseudomonas aeruginosa to collagen type I. Antimicrob Agents Chemother 39: 2645-2649.
195. Tsang KW, Rutman A, Tanaka E, Lund V, Dewar A, Cole PJ & Wilson R (1994) Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur Respir J 7: 1746-1753.
196. Ulrich M & Doring G (2004) Three-dimensional human airway epithelial cell cultures. J Cyst Fibros 3(suppl 2): 55-57.
197. Ulrich M, Berger J, Moller JG & Doring G (2005) Moxifloxacin and ciprofloxacin protect human respiratory epithelial cells against Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae in vitro. Infection 33(suppl 2): 50-54.
198. Vaughan MB, Ramirez RD, Wright WE, Minna JD & Shay JW (2006) A three-dimensional model of differentiation of immortalized human bronchial epithelial cells. Differentiation 74: 141-148.
199. Venkatakrishnan V, Packer NH & Thaysen-Andersen M (2013) Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis. Expert Rev Respir Med 7: 553-576.
200. Venkataraman A, Rosenbaum MA, Werner JJ, Winans SC & Angenent LT (2014) Metabolite transfer with the fermentation product 2, 3-butanediol enhances virulence by Pseudomonas aeruginosa. ISME J DOI: 10.1038/ismej.2013.232.
201. Vertrees RA, Zwischenberger JB, Boor PJ, Popov V, McCarthy M, Solley TN & Goodwin TJ (2008) Cellular differentiation in three-dimensional lung cell cultures. Cancer Biol Ther 7: 404-412.
202. Vikstrom E, Tafazoli F & Magnusson KE (2006) Pseudomonas aeruginosa quorum sensing molecule N-(3 oxododecanoyl)-l-homoserine lactone disrupts epithelial barrier integrity of Caco-2 cells. FEBS Lett 580: 6921-6928.
203. Villenave R, Thavagnanam S, Sarlang S etal. (2012) In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. P Natl Acad Sci USA 109: 5040-5045.
204. Villenave R, Shields MD & Power UF (2013) Respiratory syncytial virus interaction with human airway epithelium. Trends Microbiol 21: 238-244.
205. Voynow JA & Rubin BK (2009) Mucins, mucus, and sputum. Chest 135: 505-512.
206. Wagner DE, Bonvillain RW, Jensen T etal. (2013) Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds. Respirology 18: 895-911.
207. Wagner DE, Bonenfant NR, Sokocevic D etal. (2014) Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration. Biomaterials 35: 2664-2679.
208. Wallace CJ, Medina SH & Elsayed ME (2013) Effect of rhamnolipids on permeability across caco-2 cell monolayers. Pharm Res 31: 887-894.
209. Wang J, Dong Y, Zhou T etal. (2013) Pseudomonas aeruginosa cytotoxicity is attenuated at high cell density and associated with the accumulation of phenylacetic acid. PLoS One 8: e60187.
210. Weichert S, Jennewein S, Hufner E, Weiss C, Borkowski J, Putze J & Schroten H (2013) Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines. Nutr Res 33: 831-838.
211. Weiner DJ, Bucki R & Janmey PA (2003) The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am J Respir Cell Mol Biol 28: 738-745.
212. Wilson R, Roberts D & Cole P (1985) Effect of bacterial products on human ciliary function in vitro. Thorax 40: 125-131.
213. Woodworth BA, Tamashiro E, Bhargave G, Cohen NA & Palmer JN (2008) An in vitro model of Pseudomonas aeruginosa biofilms on viable airway epithelial cell monolayers. Am J Rhinol 22: 235-238.
214. Worlitzsch D, Tarran R, Ulrich M etal. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109: 317-325.
215. Wu L, Estrada O, Zaborina O etal. (2005) Recognition of host immune activation by Pseudomonas aeruginosa. Science 309: 774-777.
216. Yang L, Jelsbak L & Molin S (2011) Microbial ecology and adaptation in cystic fibrosis airways. Environ Microbiol 13: 1682-1689.
217. Yoon SS, Hennigan RF, Hilliard GM etal. (2002) Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell 3: 593-603.
218. Zaborin A, Gerdes S, Holbrook C, Liu DC, Zaborina OY & Alverdy JC (2012) Pseudomonas aeruginosa overrides the virulence inducing effect of opioids when it senses an abundance of phosphate. PLoS One 7: e34883.
219. Zaborina O, Lepine F, Xiao G etal. (2007) Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog 3: e35.
220. Zhang L, Parente J, Harris SM, Woods DE, Hancock RE & Falla TJ (2005) Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother 49: 2921-2927.
221. Zhang WJ, Lin QX, Zhang Y etal. (2011) The reconstruction of lung alveolus-like structure in collagen-matrigel/microcapsules scaffolds in vitro. J Cell Mol Med 15: 1878-1886.
222. Zhao KQ, Goldstein N, Yang H etal. (2011) Inherent differences in nasal and tracheal ciliary function in response to Pseudomonas aeruginosa challenge. Am J Rhinol Allergy 25: 209-213.
223. Zulianello L, Canard C, Kohler T, Caille D, Lacroix JS & Meda P (2006) Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect Immun 74: 3134-3147.